Pristine Biologicals NZ Ltd, a subsidiary of Indian Immunologicals Ltd (IIL), on Monday opened a new facility in Dargaville (New Zealand) for the production of sterile filtered serum. The facility was inaugurated by Meenesh C Shah, chairman of Pristine Biologicals NZ Ltd, besides being chairman of IIL and National Dairy Development Board. Mayor of Dargaville Dr Jason Smith, IIL Managing Director Dr K Anand Kumar and IIL’s GM and Director Dr Vijay Dasari were present.
Speaking on the occasion, Shah said he is glad that an investment made overseas has come good. He also mentioned that affordable vaccines made in India required a sustainable supply of quality ingredients made by Pristine.
Dr Kumar called Pristine as a success story and said plans are on the way to double the capacity soon as demands have gone up significantly. IIL, a subsidiary of the National Dairy Development Board (NDDB), established Pristine in Dargaville, Kaipara District in 2015 for the production and supply of pharmaceutical grade bovine serum used to produce many vaccines and is considered as a very successful venture.